Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study

被引：0
|
作者：
Xiao-Ling Guo
Zi-Yu Zhao
Xue-Fei Guo
Ya-Bei Zuo
Jin-Ao Li
Zi-Yuan Nie
Jin-Hai Ren
机构：
[1] The Second Hospital of Hebei Medical University,Department of Hematology
来源：
Neurological Sciences | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2931 / 2934
页数：3
相关论文
共 50 条
  • [21] Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study
    George E. Fragoulis
    Sophia Lionaki
    Aliki Venetsanopoulou
    Panayiotis G. Vlachoyiannopoulos
    Haralampos M. Moutsopoulos
    Athanasios G. Tzioufas
    Clinical Rheumatology, 2018, 37 : 737 - 747
  • [22] Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma
    Yi, Jun Ho
    Kim, Seok Jin
    Yang, Deok-Hwan
    Do, Young Rok
    Won, Jong Ho
    Baek, Dongwon
    Shin, Ho Jin
    Kim, Dae Sik
    Kim, Hyo Jung
    Kang, Ka-won
    Bae, Sung Hwa
    Kwon, Ji-Hyun
    Kwon, Jung Hye
    Park, Byeong Bae
    Kim, Won Seog
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1773 - 1781
  • [23] Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma
    Kuhlman, Justin J.
    Moustafa, Muhamad Alhaj
    Jiang, Liuyan
    Wang, Jing
    Gupta, Vivek
    Tun, Han W.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 23 - 29
  • [24] A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime
    Bairey, Osnat
    Lebel, Eyal
    Buxbaum, Chen
    Porges, Tzvika
    Taliansky, Alisa
    Gurion, Ronit
    Goldschmidt, Neta
    Shina, Tzahala Tzuk
    Zektser, Miri
    Hofstetter, Liron
    Siegal, Tali
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (05) : 838 - 847
  • [25] Orelabrutinib versus ibrutinib for patients with refractory/relapsed primary central nervous system lymphoma: An efficacy and safety analysis
    Qiao, Lijiao
    Liu, Quanxia
    Huang, Chunzhou
    MEDICINE, 2023, 102 (27) : E33880
  • [26] The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis
    Michael Brendan Cloney
    Adam M. Sonabend
    Jonathan Yun
    Jingyan Yang
    Fabio Iwamoto
    Suprit Singh
    Govind Bhagat
    Peter Canoll
    George Zanazzi
    Jeffrey N. Bruce
    Michael Sisti
    Sameer Sheth
    E. Sander Connolly
    Guy McKhann
    Journal of Neuro-Oncology, 2017, 132 : 189 - 197
  • [27] The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis
    Cloney, Michael Brendan
    Sonabend, Adam M.
    Yun, Jonathan
    Yang, Jingyan
    Iwamoto, Fabio
    Singh, Suprit
    Bhagat, Govind
    Canoll, Peter
    Zanazzi, George
    Bruce, Jeffrey N.
    Sisti, Michael
    Sheth, Sameer
    Connolly, E. Sander
    McKhann, Guy
    JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (01) : 189 - 197
  • [28] Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma
    Birsen, Rudy
    Blanc, Estelle
    Burroni, Barbara
    Broudin, Chloe
    Willems, Lise
    Legoff, Marielle
    Leray, Emmanuelle
    Pilorge, Sylvain
    Salah, Sawsen
    Quentin, Aude
    Deau-Fisher, Benedicte
    Franchi, Patricia
    Vignon, Marguerite
    Mabille, Laurence
    Nguyen, Charles
    Kirova, Youlia
    Varlet, Pascale
    Tauziede-Espariat, Arnault
    Edjlali, Myriam
    Edouard, Dezamis
    Soussain, Carole
    Houillier, Caroline
    Pallud, Johan
    Damotte, Diane
    Bouscary, Didier
    Bonnefoy, Jerome Tamburini
    BLOOD, 2017, 130
  • [29] EFFECTIVE REGIMEN OF HIGH-DOSE METHOTREXATE PLUS TEMOZOLOMIDE FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY
    Zhang, Jun-ping
    Ge, Jing-jing
    Li, Cheng
    Qi, Shao-pei
    Xue, Feng-jun
    Gao, Zhi-meng
    NEURO-ONCOLOGY, 2020, 22 : 121 - 121
  • [30] Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry
    Mocikova, Heidi
    Pytlik, Robert
    Sykorova, Alice
    Janikova, Andrea
    Prochazka, Vit
    Vokurka, Samuel
    Berkova, Adela
    Belada, David
    Campr, Vit
    Buresova, Lucie
    Trneny, Marek
    LEUKEMIA & LYMPHOMA, 2016, 57 (12) : 2777 - 2783
12345